Use of extended functions of modern insulin pumps;Nutzung der erweiterten funktionen von modernen insulinpumpen

Diabetes, Stoffwechsel und Herz

Volumn 19, Issue 6, 2010, Pages 405-412

  Kolassa, Ralf ^a   Mühlen, Hansjörg ^b   Maraun, Michael ^c   Rose, Ludger ^d   Hellenkamp, Annegret ^d   Eberlein, Gerhard ^e   Donaubauer, Bernd ^f   Busch, Klaus ^g   Häußler, Ralf Uwe ^h   Jung, Ralf ⁱ   Göbl, Roland ^f   Semmler, Sabine ^j   Kohn, Wolfgang ^k   Schulze Schleppinghof, Benno ^l   Sack, Anette ^l   Bonnermann, Stephan ^m   Thomas, Andreas ⁿ  

^a Diabetologische Schwerpunktpraxis   (Germany)

^b Diabetologischer Schwerpunkt im MCR   (Germany)

^c Kreiskrankenhaus Schopfheim   (Germany)

^d Diabetologische Schwerpunktpraxis   (Germany)

^e Diabetologische Schwerpunktpraxis   (Germany)

^f Polikum Charlottenburg ^*  (Germany)

^g Diabetologische Schwerpunktpraxis   (Germany)

^h Diabetologische Schwerpunktpraxis   (Germany)

ⁱ KRANKENHAUS SACHSENHAUSEN   (Germany)

^j MVZ Polikum Friedenau   (Germany)

^k Polikum Charlottenburg   (Germany)

^l Diabetologische Schwerpunktpraxis   (Germany)

^m KLINIKUM DORTMUND   (Germany)

ⁿ Medtronic GmbH   (Germany)

more..

Author keywords

Bolus management; Continuous glucose monitoring; Insulin pump therapy; Sensor augmented pump therapy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH EDUCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PROSPECTIVE STUDY;

EID: 78649921856     PISSN: 18617603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Koivisto VA, Yki-Jarvinen H, Helve E, Karonen SL, Pelkonen R: Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes 1986; 35: 78-82
2. Pickup JC, Kidd J, Burmiston D, Yemane N: Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia-prone type 1 diabetes. Practical Diabetes International 2005; 22 (1): 10-14 (Pubitemid 40662704)
3. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996; 19: 324-327 (Pubitemid 26115454)
4. Aragona M, Giannarelli R, Coppelli A, Palumbo F, Del Prato S, Marchetti P: Improvement of retinopathy in type 1 diabetic patients treated with continuous subcutaneous insulin infusion (CSII). Diabetes Metabol 2003; 29: 4S235
5. Lüddeke HJ, Hofmann W, Guder WG, Renner R: Urinary albumin concentration in 52 CSII treated type 1 diabetic patients during a follow-up of 4 years. Diabetes und Stoffwechsel 2002; 11 (Suppl 1): 115
6. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M: Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabetic Medicine 2002; 19: 746-751
7. DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621
8. DECODE Study Group: Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26: 688-696
9. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow up. Diabetologia 1996; 39: 1577-1583 (Pubitemid 26397370)
10. Ohkubo Y Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117
11. Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23: B21-B29
12. Piconi L, Quagliaro L, DaRos R, Assaloni R, Giugliano D, Esposito K, Szabo C, Ceriello A: Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly (ADP-ribose) polymerase. J Thromb Haemost 2004; 2: 1453-1459
13. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A: Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001; 281: E924-E930
14. Ceriello A, Kumar S, Piconi L, Esposito K, Giugliano D: Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. Diabetes Care 2007; 30: 649-654 (Pubitemid 46357401)
15. Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR: Early onset of subclinical atherosclerosis in young patients with type 1 diabetes. J Pediatr 2004; 145: 452-457 (Pubitemid 39345979)
16. Gross TM, Kayne D, King A, Rother C, Juth S: A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther 2003; 5: 365-369 (Pubitemid 36676310)
17. Jankovec Z: Frequency of available insulin pump functions use by patients with diabetes mellitus. 1st ATTD Meeting, Prague 2008, Proceedings 112
18. Edition Medtronic: ConClusio Schulungsprogramm zum kontinuierlichen Glukosemonitoring und zur sensorunterstützten Insulinpumpentherapie. 2010
19. Raccah D, Sulmont V, Reznik Y, Guerci B, Hanaire H, Jeandidier N, Nicolino M: Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes. Diabetes Care 2009; 32: 2245-2250